FOEHR MATTHEW W — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
FOEHR MATTHEW W is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $773K.
Profile
Matthew W. Foehr is an experienced executive in the biotechnology sector, currently serving as President and CEO of OmniAb, Inc. He has held multiple roles in the industry, including leadership positions at Viking Therapeutics, Inc. His expertise lies in therapeutic antibody discovery technologies and drug development.
Matthew W. Foehr is an experienced executive in the biotechnology sector, currently serving as President and CEO of OmniAb, Inc. He has held multiple roles in the industry, including leadership positions at Viking Therapeutics, Inc. His expertise lies in therapeutic antibody discovery technologies and drug development.…
Has FOEHR MATTHEW W been buying or selling stock?
Recorded transactions: 0 open-market purchases () and 6 open-market sales ($773K) across all tracked filings.
Where can I see all of FOEHR MATTHEW W's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
